Goldman Sachs Group Inc Orchard Therapeutics PLC Transaction History

Goldman Sachs Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 May 14, 2024	BUY	$0.36 - $0.49 $7,280 - $9,909	20,223 New	20,223 $7,000
Q4 2022 Feb 13, 2023	BUY	$0.36 - $0.49 $7,280 - $9,909	20,223 New	20,223 $7,000
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.78 $15,453 - $28,699	-36,794 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.7 - $1.51 $25,576 - $55,172	-36,538 Reduced 49.83%	36,794 $26,000
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.23 $48,716 - $93,653	41,997 Added 134.03%	73,332 $97,000
Q3 2021 Nov 10, 2021	BUY	$2.24 - $4.29 $70,190 - $134,427	31,335 New	31,335 $72,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.